Search

Author/Creator List, Alan

1. Impact of baseline cytogenetic findings and cytogenetic response on outcome of high-risk myelodysplastic syndromes and low blast count AML treated with azacitidine. (December 2017)

Authors:
Sébert, Marie; Komrokji, Rami S; Sekeres, Mikkael A.; Prebet, Thomas; Cluzeau, Thomas; Santini, Valeria; Gyan, Emmanuel; Sanna, Alessandro; Ali, Najla HAl; Hobson, Sean; Eclache, Virginie; List, Alan; Fenaux, Pierre; Adès, Lionel
Journal:
Leukemia research
Issue:
Volume 63(2017:Dec.)
Page Start:
72
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide. (20th April 2016)

Authors:
Rollison, Dana E.; Shain, Kenneth H.; Lee, Ji‐Hyun; Hampras, Shalaka S.; Fulp, William; Fisher, Kate; Al Ali, Najla H.; Padron, Eric; Lancet, Jeffrey; Xu, Qiang; Olesnyckyj, Martha; Kenvin, Laurie; Knight, Robert; Dalton, William; List, Alan; Komrokji, Rami S.
Journal:
Cancer medicine
Issue:
Volume 5:Number 7(2016:Jul.)
Page Start:
1694
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Validation of International Working Group response criteria in higher‐risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium. (22nd December 2020)

Authors:
Komrokji, Rami S.; Al Ali, Najla H; Sallman, David; Padron, Eric; DeZern, Amy E.; Barnard, John; Roboz, Gail J.; Garcia‐Manero, Guillermo; List, Alan; Steensma, David P.; Sekeres, Mikkael A.
Journal:
Cancer medicine
Issue:
Volume 10:Number 2(2021)
Page Start:
447
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗